subject: FDA rejects another weight-loss drug [print this page]

---

Early in October, the maker of the obesity drug sibutramine (Meridian) voluntarily agreed to remove it from the U.S. market because of increased risk of stroke and myocardial infarction

FDA rejects another weight-loss drug

By: alam.md

---

welcome to loan (http://www.yloan.com/)

Powered by Discuz! 5.5.0